SLP
$11.92
Simulations Plus, Inc.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through Softwar...
Recent News
Adobe Systems (ADBE) Q1 Earnings and Revenues Top Estimates
Adobe (ADBE) delivered earnings and revenue surprises of +3.10% and +1.86%, respectively, for the quarter ended February 2026. Do the numbers hold clues to what lies ahead for the stock?
Simulations Plus AGM: Shareholders Approve All Proposals, Back Annual Say-on-Pay Votes
Simulations Plus (NASDAQ:SLP) held its annual meeting of shareholders in a virtual format, with CEO Shawn O’Connor chairing the proceedings and CFO and Corporate Secretary Will Frederick presenting the formal business items and preliminary voting results. Virtual meeting format and shareholder part
Seagate's Q2 Earnings Top, Revenues Soar Y/Y on AI-Led Storage Demand
STX tops fiscal Q2 2026 earnings and revenue, sees strong data center demand, record margins and upbeat fiscal Q3 outlook as nearline capacity ramps.
Be Wary Of SLP Resources Berhad (KLSE:SLP) And Its Returns On Capital
Ignoring the stock price of a company, what are the underlying trends that tell us a business is past the growth phase...
Estimating The Intrinsic Value Of Simulations Plus, Inc. (NASDAQ:SLP)
Key Insights Simulations Plus' estimated fair value is US$22.01 based on 2 Stage Free Cash Flow to Equity With US$20.33...